| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |